Exploring Canine Mammary Cancer through Liquid Biopsy: Proteomic Profiling of Small Extracellular Vesicles
Authors:
- Adriana Alonso NovaisANAdriana Alonso Novais
- Guilherme Henrique TamarindoGTGuilherme Henrique Tamarindo
- Luryan Mikaelly Minotti MeloLMLuryan Mikaelly Minotti Melo
- Beatriz Castilho BalieiroBBBeatriz Castilho Balieiro
- Daniela NobregaDNDaniela Nobrega
- Gislaine dos SantosGSGislaine dos Santos
- Schaienni Fontoura SaldanhaSSSchaienni Fontoura Saldanha
- Fabiana Ferreira de SouzaFSFabiana Ferreira de Souza
- Luiz Gustavo de Almeida ChuffaLuiz Gustavo de Almeida Chuffa
- Shay BrachaSBShay Bracha
- Debora Aparecida Pires de Campos ZuccariDebora Aparecida Pires de Campos Zuccari
Preprint
- 23 May 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
(Background) Canine mammary tumors (CMT) have emerged as an important model for understanding pathophysiological aspects of human disease. Liquid biopsy (LB), which relies on blood-borne biomarkers and offers minimal invasiveness, holds promise for reflecting the disease status of patients. Small extracellular vesicles (SEVs) and their protein cargo have recently gained attention as potential tools for disease screening and monitoring. (Objectives) This study aimed to isolate SEVs from canine patients and analyze their proteomic profile to assess their diagnostic and prognostic potential. (Methods) Plasma samples were collected from female dogs grouped into CMT (malignant and benign), healthy controls, relapse, and remission groups. SEVs were isolated and characterized using ultracentrifugation (UC), nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Proteomic analysis of circulating SEVs was conducted using Liquid Chromatography–Mass Spectrometry (LC–MS). (Results) While no significant differences were observed in the concentration and size of exosomes among the studied groups, proteomic profiling revealed important variations. Mass spectrometry identified exclusive proteins that could serve as potential biomarkers for mammary cancer. These included Inter-alpha-trypsin inhibitor heavy chain (ITIH2 and ITI4), phosphopyruvate hydratase or alpha enolase (ENO1), eukaryotic translation elongation factor 2 (eEF2), actin (ACTB), transthyretin (TTR), beta-2-glycoprotein 1 (APOH) and gelsolin (GSN) found in female dogs with malignant tumors. Additionally, Vitamin D-binding protein (VDBP), also known as group-specific component (GC), was identified as a protein present during remission. (Conclusion) The results underscore the potential of proteins found in SEVs as valuable biomarkers in CMT. Despite the lack of differences in vesicle concentration and size between the groups, the analysis of protein content revealed promising markers with potential applications in CMT diagnosis and monitoring. These findings suggest a novel approach in the development of more precise and effective diagnostic tools for this challenging clinical condition.Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- PANTHER: Making genome‐scale phylogenetics accessible to allProtein Science, 2021
- Apolipoproteins and cancerCancer Medicine, 2019
- Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressivenessBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2017
- Identification of novel serum peptides biomarkers for female breast cancer patients in Western ChinaProteomics, 2015
- Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cellsCell Stress and Chaperones, 2014
- Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterpartsElectrophoresis, 2013
- The absolute quantification of eight inter‐α‐trypsin inhibitor heavy chain 4 (ITIH4)‐derived peptides in serum from breast cancer patientsProteomics – Clinical Applications, 2010
- Proteomic profiling of exosomes: Current perspectivesProteomics, 2008
- Tissue microarray analysis of cytoskeletal actin‐associated biomarkers gelsolin and E‐cadherin in urothelial carcinomaCancer, 2002
- Epigenetic Regulation of Gelsolin Expression in Human Breast Cancer CellsExperimental Cell Research, 1999